I agree that this site is using cookies. You can find further informations here.
X
PAPP, Kim
695  results:
Search for persons X
?
1

Roflumilast Cream 0.15% in Patients with Atopic Dermatitis:..:

Simpson, Eric ; Eichenfield, Lawrence ; Del Rosso, James...
SKIN The Journal of Cutaneous Medicine.  8 (2024)  2 - p. s372 , 2024
Link: https://doi.org/10.25251..
 
?
2

Tapinarof cream 1% once daily: Significant efficacy in the ..:

Silverberg, Jonathan I. ; Eichenfield, Lawrence F. ; Hebert, Adelaide A....
Journal of the American Academy of Dermatology.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Guselkumab Reduces Disease- and Mechanism-Related Biomarker..:

Blauvelt, Andrew ; Langley, Richard G. ; Branigan, Patrick J....
JID Innovations.  4 (2024)  5 - p. 100287 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Efficacy and Safety of Risankizumab for Active Psoriatic Ar..:

Kristensen, Lars Erik ; Keiserman, Mauro ; Papp, Kim...
Rheumatology and Therapy.  11 (2024)  3 - p. 617-632 , 2024
Link: https://doi.org/10.1007/..
 
?
5

Efficacy and Safety of Risankizumab for Active Psoriatic Ar..:

Östör, Andrew ; Van den Bosch, Filip ; Papp, Kim...
Rheumatology and Therapy.  11 (2024)  3 - p. 633-648 , 2024
Link: https://doi.org/10.1007/..
 
?
6

Association of disease duration and PASI response rates at ..:

Pinter, Andreas ; Eyerich, Kilian ; Costanzo, Antonio...
Journal of Dermatological Treatment.  35 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
7

Efficacy and safety of apremilast in patients with moderate..:

Merola, Joseph F. ; Parish, Lawrence Charles ; Guenther, Lyn...
Journal of the American Academy of Dermatology.  90 (2024)  3 - p. 485-493 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Efficacy of brodalumab in moderate-to-severe plaque psorias..:

Papp, Kim ; Prajapati, Vimal H. ; Maari, Catherine...
Journal of the American Academy of Dermatology.  90 (2024)  6 - p. 1254-1256 , 2024
Link: https://doi.org/10.1016/..
 
?
9

502 - Efficacy and safety of upadacitinib through 140 weeks..:

Silverberg, Jonathan I ; Guttman-Yassky, Emma ; Simpson, Eric L...
British Journal of Dermatology.  190 (2024)  Supplement_2 - p. ii8-ii8 , 2024
Link: https://doi.org/10.1093/..
 
?
10

Deucravacitinib in Plaque Psoriasis: 3-year Safety and Effi..:

Armstrong, April W. ; Lebwohl, Mark ; Warren, Richard B....
SKIN The Journal of Cutaneous Medicine.  8 (2024)  2 - p. s366 , 2024
Link: https://doi.org/10.25251..
 
?
11

514 - Tapinarof cream 1% once daily: significant efficacy i..:

Silverberg, Jonathan I ; Eichenfield, Lawrence F ; Hebert, Adelaide A...
British Journal of Dermatology.  190 (2024)  Supplement_2 - p. ii17-ii18 , 2024
Link: https://doi.org/10.1093/..
 
?
12

Roflumilast Cream 0.3% in Patients With Chronic Plaque Psor..:

Del Rosso, James ; Hong, H. Chih-ho ; Kircik, Leon...
SKIN The Journal of Cutaneous Medicine.  8 (2024)  2 - p. s355 , 2024
Link: https://doi.org/10.25251..
 
?
13

Roflumilast Cream 0.3% in Patients with Chronic Plaque Psor..:

Del Rosso, James ; Hong, H. Chih-ho ; Kircik, Leon...
SKIN The Journal of Cutaneous Medicine.  8 (2024)  1 - p. s310 , 2024
Link: https://doi.org/10.25251..
 
?
14

Cedirogant in adults with psoriasis: a phase 2, randomized,..:

Tyring, Stephen ; Moore, Angela ; Morita, Akimchi...
Clinical and Experimental Dermatology.  , 2024
Link: https://doi.org/10.1093/..
 
?
15

Efficacy, Safety, and Long-Term Disease Control of Ruxoliti..:

Eichenfield, Lawrence F. ; Simpson, Eric L. ; Papp, Kim...
American Journal of Clinical Dermatology.  25 (2024)  4 - p. 669-683 , 2024
Link: https://doi.org/10.1007/..
 
1-15